Trial intelligence / Profile preview

Sodium Nitrite Infusion in Hypertension

NCT02527837Phase 1Unknown

Start
May 2015
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in hypertension (HTN) comparing Sodium Nitrite with Placebo (2 arms). Primary endpoint: Fractional urinary sodium excretion at 1 day. Status: unknown.

02

Drugs

sodium nitrite
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02527837.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02527837.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call